Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Cancer Année : 2010

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion

N. M. Santio
  • Fonction : Auteur
R. L. Vahakoski
  • Fonction : Auteur
E.-M. Rainio
  • Fonction : Auteur
J. A. Sandholm
  • Fonction : Auteur
S. S. Virtanen
  • Fonction : Auteur
P. J. Koskinen
  • Fonction : Auteur correspondant
  • PersonId : 882683

Connectez-vous pour contacter l'auteur

Résumé

BACKGROUND Pim family kinases are small constitutively active serine/threonine-specific kinases, elevated levels of which have been detected in human hematopoietic malignancies as well as in solid tumours. While we and others have previously shown that the oncogenic Pim kinases stimulate survival of hematopoietic cells, we now examined their putative role in regulating motility of adherent cancer cells. For this purpose, we inhibited Pim kinase activity using a small molecule compound, 1,10-dihydropyrrolo[2,3-a]carbazole-3-carbaldehyde (DHPCC-9), which we had recently identified as a potent and selective inhibitor for all Pim family members. RESULTS We now demonstrate that the Pim kinase inhibitor DHPCC-9 is very effective also in cell-based assays. DHPCC-9 impairs the anti-apoptotic effects of Pim-1 in cytokine-deprived myeloid cells and inhibits intracellular phosphorylation of Pim substrates such as Bad. Moreover, DHPCC-9 slows down migration and invasion of cancer cells derived from either prostate cancer or squamocellular carcinoma patients. Silencing of Pim expression reduces cell motility, while Pim overexpression enhances it, strongly suggesting that the observed effects of DHPCC-9 are dependent on Pim kinase activity. Interestingly, DHPCC-9 also abrogates NFATc-dependent migration of cancer cells, implying that NFATc factors mediate at least part of the pro-migratory effects of Pim kinases. CONCLUSIONS Altogether, our data indicate that DHPCC-9 is not only a powerful tool to investigate physiological effects of the oncogenic Pim family kinases, but also an attractive molecule for drug development to inhibit invasiveness of Pim-overexpressing cancer cells.

Dates et versions

hal-00536019 , version 1 (15-11-2010)

Identifiants

Citer

N. M. Santio, R. L. Vahakoski, E.-M. Rainio, J. A. Sandholm, S. S. Virtanen, et al.. Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion. Molecular Cancer, 2010, 9 (279), pp.1-13. ⟨10.1186/1476-4598-9-279⟩. ⟨hal-00536019⟩
62 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More